Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-25 @ 5:19 AM
NCT ID: NCT05704127
Eligibility Criteria: Inclusion Criteria: * 1.It is consistent with the diagnostic criteria of low back pain and the syndrome differentiation criteria of cold and wet lumbar muscle strain. * 2.There is no gender limitation, and the age should be between 25 and 70 years old * 3.No treatment of traditional Chinese and western medicine related to lumbago was received in the past 2 weeks * 4.The course of disease was controlled within 8 years * 5.Informed consent, willing to cooperate with the whole treatment * 6.Agree to record the scale score and volunteer to participate in this experiment * 7.At least one contact information should be reserved for patients to receive follow-up visits * 8.In order to reduce the rate of shedding, priority is included in hospitalized patients Exclusion Criteria: * 1.Patients do not meet the inclusion criteria Patients who do not meet the diagnostic inclusion criteria of this subject * 2.The patient is in the pregnancy or lactation period * 3.Patients are allergic to moxibustion smoke, and it is difficult to accept moxibustion treatment * 4.The patient suffers from diseases of the blood and immune system * 5.Patients with cardiac, liver and renal insufficiency * 6.The patient suffers from mental illness and cannot cooperate with moxibustion * 7.The patient suffered from lumbar spine tuberculosis, bone cancer and other diseases, which affected the experimental results
Healthy Volunteers: False
Sex: ALL
Minimum Age: 25 Years
Maximum Age: 70 Years
Study: NCT05704127
Study Brief:
Protocol Section: NCT05704127